Gene-Disorder Association · Article
Gene
CAMK2B Calcium/Calmodulin Dependent Protein Kinase II Beta
×
First reported
1950
Supporting publications
1
Approved treatment annotated
Association Review
In brief The association between CAMK2B (Calcium/Calmodulin Dependent Protein Kinase II Beta) and Renal Cell Carcinoma is reported, supported by a single source.
Sources
1
Clinical variants
0
Symptoms
1
Compounds
1
Trials
86 of 709 via CAMK2B compounds
Publications
1
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Renal Cell Carcinoma
The disorder 8 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Interventions
Therapeutics 1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials 709 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
1 publication
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
08
Provenance
References & sources 7 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access